Important information about your Desyncra® for Tinnitus therapy

Dear Sir/Madam,   In the event that your Desyncra® for Tinnitus iPod is no longer functional, we regret to inform you that Desyncra® for Tinnitus therapy can no longer be taken advantage of. Due to bureaucratic obstacles on the part of the licensor, it was not possible to maintain current connections. Unfortunately, all efforts made in this regard were in vain. For this reason, the app is no longer available and will be withdrawn from the market.   Unfortunately, no further information about this is available.   We ask that you please take note of this, and we wish you all the best!

Wichtige Information zu Ihrer Desyncra® for Tinnitus Therapie

Sehr geehrte Damen und Herren! Falls Ihr Desyncra® for Tinnitus iPod nicht mehr funktionstüchtig ist, müssen wir Ihnen leider mitteilen, dass die Desyncra® for Tinnitus Therapie nicht länger in Anspruch genommen werden kann. Aufgrund von bürokratischen Hindernissen von Seiten des Lizenzgebers konnten aktuelle Verbindungen nicht aufrechterhalten werden. Alle Bemühungen in diesem Zusammenhang waren leider vergebens. Die App ist aus diesem Grund nicht mehr verfügbar und wird vom Markt genommen werden. Weitere Informationen dazu stehen leider nicht zur Verfügung. Wir ersuchen um Kenntnisnahme & wünschen Ihnen alles Gute!

Informations importantes sur Desyncra® pour le traitement vos acouphènes

Mesdames, Messieurs,   Si votre iPod Desyncra® pour le traitement vos acouphènes (adapted iPod for Tinitus Therapy) n’est plus fonctionnel, nous avons le regret de vous informer que Desyncra® for Tinnitus Therapy ne peut plus être utilisé. En raison d’obstacles bureaucratiques de la part du donneur de licence, les connexions actuelles n’ont pas pu être maintenues. Malheureusement, tous les efforts en la matière ont été vains. C’est pour cette raison que l’application n’est plus disponible et sera retirée du marché.   Malheureusement, nous ne disposons pas d’informations supplémentaires.   Nous vous demandons d’en prendre note et vous souhaitons le meilleur !

Desyncra™ – Rewiring the brain

Desyncra™ – Rewiring the brain

A new way to reduce symptoms

A new way to reduce symptoms

Sounds good. Feels better.

Sounds good. Feels better.


The Desyncra™ offering at a glance

German-based medical company Desyncra™ offers tremendous marketing opportunities through an all-new technology: Non-Invasive Neuromodulation. The groundbreaking technology was developed by a team of brain scientists, neurologists, engineers and IT-specialists led by medical device expert Dr Markus Haller. Accessing the brain to open up cures for multiple neural conditions: Tomorrow is now!

Treatment systems
Components per system

Years of research
Clinical trials
Desyncra™ for Tinnitus
A new way to reduce tinnitus: More than 4000 patients have been successfully treated with this clinically tested acoustic CR® Neuromodulation. All tests show similar results: Desyncra™ For Tinnitus is successful in more than 75% of treated subjects.
Desyncra™ for Tremor
Desyncra for Tremor uses CR® Neuromodulation as a powerful tool to treat a range of movement disorders, for example; Parkinson’s disease related tremor, and other movement disorders such as dystonia and many other neurological conditions.
Desyncra™ for Migraine
Good news for patients with migraine: Desyncra has developed a treatment on the basis of CR® Neuromodulation to manage pain, aura and nausea through stimulating neural patterns in the brain using visual stimulation.
Desyncra™ Hearing Aid
Quite frequently, tinnitus patients are also hearing impaired. Our own full spectrum hearing aid device works perfectly with Desyncra for Tinnitus and provides its users with a first-class product that makes life easier.

Curing the condition, not just stopping symptoms

Desyncra™ systems are targeted: Propriety, Coordinated Reset, Non Invasive Neuromodulation. Accessing the brain to open up cures for multiple neural conditions.

Great things come
to those who sign up

Stay up to date with Desyncra’s newsletter featuring latest product updates, previews and more.

Sign up


Call us: EU: +49 (0) 2641 912 – 8787 US: +1 818-989-1001